My Publications in 2024

Here is the list of my papers that were published in 2024. Manuscripts were published in Value in Health, BMJ Open, Journal of Comparative Effectiveness Research, Forum for Health Economics and Policy, Annals of the American Thoracic Society and others. Links to all papers are below. Clayton D, Shafrin J, Yen GP, Geevarghese L, Shi…

China’s transition to DRG-based hospital reimbursement

China has been transitioning from a fee-for-service (FFS) payment system to a Diagnosis-Related Group (DRG) payment system for hospitals in various cities. Under the FFS model, hospitals were reimbursed for each individual healthcare service provided, which created incentives to increase the number of services during a patient’s hospitalization. In June 2019, the National Healthcare Security…

How will AI change health care in 2025?

To answer this question, I of course asked different AIs what the answer would be. Their responses: ChatGPT. In 2025, AI will significantly enhance healthcare by improving diagnostic accuracy, such as detecting early-stage cancers through tools like AI-enhanced mammograms and identifying retinal diseases via AI-analyzed optical scans. Personalized medicine will advance as AI tools like…

Top 10 Healthcare Economist posts of 2024

What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices The world is relying on the United States to get value-based drug pricing right Why is the market design…

Links

Sanofi joins 340B lawsuit. Kaiser behavioral health workers on strike. Apologia of PBMs. Status of brain-computer interfaces.  How old is the moon?

2024 Books of the year

Below are my favorite books of the year. These are my favorite books that I read this year, not necessarily books that came out this year. On to the list! BOOK OF THE YEAR Nature’s Metropolis: Chicago and the Great West by William Cronon. I learned so much from this book. It discusses the development…

Evolution of orphan drug

A study by Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug Act of 1983 was passed in the US. The authors use FDA data to evaluate between 1983 and 2022 and find that: Over the 40 years of the ODA, 6,340 orphan drug designations were granted, representing…

Trump, RFK Jr. and Vaccines

The Washington Post reports on a meeting between President-elect Trump, Robert F. Kennedy, Jr. and a number of CEOs of pharmaceutical firms. When the topic turned to vaccines, the discussion was not about banning the products, the three people said. Kennedy spoke about the need for better study of the vaccine dosing schedule for newborns…